A study of hematological complications occurring in patients with polycythemia vera treated with 32-P (based on a series of 296 patients).
D000741:Anemia, Aplastic / Q000209:etiology; D005260:Female; D006402:Hematologic Diseases / Q000453:epidemiology; D006801:Humans; D007938:Leukemia / Q000209:etiology; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010759:Phosphorus Isotopes / Q000008:administration & dosage*; D011087:Polycythemia Vera / Q000150:complications*; D055728:Primary Myelofibrosis / Q000209:etiology; D013163:Splenomegaly / Q000209:etiology
D010759:Phosphorus Isotopes